CASI(CASI) - 2024 Q4 - Annual Report

Exhibit 99.1 CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 BUSINESS AND FINANCIAL RESULTS BEIJING, China (March 31, 2025) CASI Pharmaceuticals, Inc. (Nasdaq: CASI, "CASI"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the fourth quarter ended December 31, 2024, and provided an update on key highlights for 2024. Wei-Wu He, Ph.D., CASI's Chairma ...